Clinical Trial Update: High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy for cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Cancer of Cervix, Cervical Cancer | Phase 3 | Status: COMPLETED